Scarica l'app Stockscreener
5.33
0.76%
0.04
Dopo l'orario di chiusura:
5.43
0.10
+1.88%
Precedente Chiudi:
$5.29
Aprire:
$5.37
Volume 24 ore:
725.49K
Relative Volume:
0.94
Capitalizzazione di mercato:
$295.65M
Reddito:
$163.78M
Utile/perdita netta:
$25.88M
Rapporto P/E:
8.20
EPS:
0.65
Flusso di cassa netto:
$-28.66M
1 W Prestazione:
+3.50%
1M Prestazione:
+25.41%
6M Prestazione:
+70.29%
1 anno Prestazione:
-32.62%
Intervallo 1D:
$5.265
$5.55
Intervallo di 1 settimana:
$4.72
$5.55
Portata 52W:
$2.645
$8.275
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Nome
Voyager Therapeutics Inc
Settore
Industria
Telefono
857-259-5340
Indirizzo
75 HAYDEN AVENUE, LEXINGTON, MA
Confronta VYGR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
5.33 | 276.23M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-02 | Iniziato | Citigroup | Buy |
| 2024-11-29 | Ripresa | Wedbush | Outperform |
| 2024-10-16 | Iniziato | Leerink Partners | Outperform |
| 2024-03-26 | Iniziato | Guggenheim | Buy |
| 2024-03-19 | Iniziato | H.C. Wainwright | Buy |
| 2024-03-07 | Iniziato | Citigroup | Buy |
| 2024-01-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | Iniziato | Truist | Buy |
| 2023-03-10 | Iniziato | Oppenheimer | Outperform |
| 2021-10-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-02-03 | Downgrade | Wedbush | Outperform → Neutral |
| 2020-12-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-11-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Iniziato | Oppenheimer | Outperform |
| 2018-11-15 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-09-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-12 | Downgrade | Evercore ISI | Outperform → In-line |
| 2018-03-12 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-02-02 | Iniziato | Morgan Stanley | Overweight |
| 2017-11-28 | Ripresa | Piper Jaffray | Overweight |
| 2017-10-31 | Iniziato | Robert W. Baird | Outperform |
| 2017-10-27 | Iniziato | Canaccord Genuity | Buy |
| 2017-10-23 | Reiterato | Stifel | Buy |
| 2017-10-12 | Iniziato | Raymond James | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-28 | Ripresa | Stifel | Buy |
Mostra tutto
Voyager Therapeutics Inc Borsa (VYGR) Ultime notizie
Is Voyager Therapeutics Inc. stock affected by interest rate hikesQuarterly Investment Review & Low Risk Investment Opportunities - newser.com
Applying Elliott Wave Theory to Voyager Therapeutics Inc.Rate Cut & Community Trade Idea Sharing - newser.com
Price action breakdown for Voyager Therapeutics Inc.IPO Watch & Low Risk Investment Opportunities - newser.com
Voyager Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Using portfolio simulators with Voyager Therapeutics Inc. includedWeekly Loss Report & Safe Capital Growth Tips - newser.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Is Voyager Therapeutics Inc a good long term investmentLow Risk Investment Ideas & High Return Portfolio Growth - earlytimes.in
What drives Voyager Therapeutics Inc stock priceEarnings Volatility Patterns & AI Alerts You Can Actually Trust - earlytimes.in
Exit strategy if you’re trapped in Voyager Therapeutics Inc.Quarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
How moving averages guide Voyager Therapeutics Inc. trading2025 Short Interest & Stock Market Timing Techniques - newser.com
Voyager Therapeutics (NASDAQ:VYGR) Earns Sell (D) Rating from Weiss Ratings - MarketBeat
Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Voyager Therapeutics (NASDAQ:VYGR) CFO Nathan Jorgensen Sells 7,666 Shares - MarketBeat
Why Momentum Traders Are Watching Glenmark Pharmaceuticals Limited Stock CloselyCandlestick Trading Patterns & Next-Level Stock Intelligence, Now Free - earlytimes.in
Oppenheimer Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $18 - 富途牛牛
Does Voyager Therapeutics Inc. show high probability of reboundQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Voyager Therapeutics Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & Superior Capital Appreciation - earlytimes.in
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Held Back By Insufficient Growth Even After Shares Climb 27% - simplywall.st
Strs Ohio Makes New Investment in Voyager Therapeutics, Inc. $VYGR - MarketBeat
Goldman Sachs Group Inc. Sells 67,877 Shares of Voyager Therapeutics, Inc. $VYGR - Defense World
Can Voyager Therapeutics Inc. hit a new high this monthJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
What recovery options are there for Voyager Therapeutics Inc.2025 Volatility Report & Low Drawdown Momentum Trade Ideas - newser.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Exit Recap: Is Voyager Therapeutics Inc stock a smart retirement pickJuly 2025 Analyst Calls & Safe Entry Point Identification - khodrobank.com
Pullback Watch: How does Voyager Therapeutics Inc compare to its peersPortfolio Risk Report & Verified High Yield Trade Plans - khodrobank.com
Aug Retail: Is DigiAsia Corp. currently under institutional pressureJuly 2025 Update & Reliable Entry Point Trade Alerts - khodrobank.com
Is Voyager Therapeutics Inc. trending in predictive chart modelsWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Voyager Therapeutics (NASDAQ:VYGR) Earns "Buy" Rating from HC Wainwright - MarketBeat
Market Fear: Can Voyager Therapeutics Inc continue delivering strong returnsMarket Sentiment Report & Technical Entry and Exit Alerts - khodrobank.com
Trading Recap: Can Voyager Therapeutics Inc continue delivering strong returnsAnalyst Downgrade & Growth Oriented Trade Recommendations - خودرو بانک
Inflation Data: Is Voyager Therapeutics Inc a stock for growth or value investorsCEO Change & AI Optimized Trading Strategy Guides - خودرو بانک
Buyout Rumor: Is Voyager Therapeutics Inc. subject to activist investor interest2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Combining price and volume data for Voyager Therapeutics Inc.Price Action & Safe Investment Capital Preservation Plans - newser.com
Voyager Therapeutics Inc Azioni (VYGR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):